COCRYSTAL PHARMA

cocrystal-pharma-logo

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The Company is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). C... C-31244 is currently being evaluated in Phase 2a studies for the treatment of hepatitis C as part of a cocktail for ultra-short therapy. Cocrystal recently entered into an exclusive worldwide license and collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop certain proprietary influenza A/B antiviral agents. CC-42344, the Companyโ€™s molecule for the treatment of influenza A, is currently being evaluated in preclinical IND-enabling studies. In addition, the Company has a pipeline of promising early preclinical programs and continues to identify and develop non-nucleoside polymerase inhibitors for norovirus gastroenteritis using the Companyโ€™s proprietary structure-based drug design technology platform.

#SimilarOrganizations #People #Financial #Website #More

COCRYSTAL PHARMA

Social Links:

Industry:
Biotechnology Clinical Trials Therapeutics

Founded:
2004-01-01

Address:
Bothell, Washington, United States

Country:
United States

Website Url:
http://www.cocrystalpharma.com

Total Employee:
11+

Status:
Active

Contact:
833-475-8247

Email Addresses:
[email protected]

Total Funding:
85.2 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache


Similar Organizations

alzheon-logo

Alzheon

Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

cohbar-logo

CohBar

CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics.

genep-logo

GenEp

GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

inhibrx-logo

Inhibrx

Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

rebus-biosystems-logo

Rebus Biosystems

Rebus Biosystems is a life science technology company creating revolutionary tools to enable spatial omics research without compromise.

recensa-therapeutics-logo

Recensa Therapeutics

Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.

stealth-biotherapeutics-logo

Stealth BioTherapeutics

Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.

Current Employees Featured

not_available_image

Roger Kornberg
Roger Kornberg Co-Founder & Chief Scientist @ Cocrystal Pharma
Co-Founder & Chief Scientist

james-martin_image

James Martin
James Martin Interim Co-CEO and Chief Financial Officer @ Cocrystal Pharma
Interim Co-CEO and Chief Financial Officer
2017-04-01

not_available_image

Gary Wilcox
Gary Wilcox Co-Founder and Vice Chairman of the Board of Directors @ Cocrystal Pharma
Co-Founder and Vice Chairman of the Board of Directors
2008-01-01

not_available_image

Sam Lee
Sam Lee Interim Co-CEO, President, and Co-Founder @ Cocrystal Pharma
Interim Co-CEO, President, and Co-Founder
2007-01-01

Founder


not_available_image

Gary Wilcox

not_available_image

Roger Kornberg

not_available_image

Sam Lee

Stock Details


Company's stock symbol is NASDAQ:COCP

Acquisitions List

Date Company Article Price
2014-11-25 RFS Pharma RFS Pharma acquired by Cocrystal Pharma N/A

Official Site Inspections

http://www.cocrystalpharma.com Semrush global rank: 2.08 M Semrush visits lastest month: 10 K

  • Host name: ec2-54-208-101-55.compute-1.amazonaws.com
  • IP address: 54.208.101.55
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Cocrystal Pharma"

Profile :: Cocrystal Pharma, Inc. (COCP)

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases.See details»

Overview :: Cocrystal Pharma, Inc. (COCP)

We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»

Overview :: Cocrystal Pharma, Inc. (COCP)

We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»

Cocrystal Pharma - Crunchbase Company Profile

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses.See details»

Cocrystal Pharma, Inc. - LinkedIn

Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of COVID-19 โ€ฆSee details»

Cocrystal Pharma, Inc. (COCP) Company Profile & Overview

Dec 9, 2024 Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases.See details»

Annual Reports :: Cocrystal Pharma, Inc. (COCP)

We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»

Cocrystal Pharma - Craft

Sep 4, 2024 Cocrystal Pharma has 3 employees across 2 locations and $2.01 m in annual revenue in FY 2020. See insights on Cocrystal Pharma including office locations, competitors, โ€ฆSee details»

Cocrystal Pharma Announces First-Patient-In for Phase 2a Human ...

Dec 6, 2023 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โ€ฆSee details»

Cocrystal Pharma Completes $4 Million Private Placement Priced โ€ฆ

BOTHELL, Wash., April 10, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces the completion of a private placement of โ€ฆSee details»

Contact Us :: Cocrystal Pharma, Inc. (COCP)

We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»

Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan โ€ฆ

Apr 24, 2023 We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments.See details»

Cocrystal Pharma Reports First Quarter 2024 Financial Results and ...

Mar 31, 2024 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โ€ฆSee details»

Cocrystal Pharma Reports Third Quarter 2023 Financial Results and ...

Nov 13, 2023 Enrollment underway in Phase 1 trial with novel protease inhibitor CDI-988, the first potential dual coronavirus-norovirus oral antiviralDosing expected to begin later this year โ€ฆSee details»

Cocrystal Pharma Reports 2021 Financial Results and Provides โ€ฆ

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โ€ฆSee details»

Cocrystal Pharma Reports First Quarter 2023 Financial Results and ...

May 15, 2023 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โ€ฆSee details»

Cocrystal Pharma Reports First Quarter 2022 Financial Results and ...

May 11, 2022 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โ€ฆSee details»

Cocrystal Pharma Reports 2022 Financial Results and Provides โ€ฆ

Mar 29, 2023 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โ€ฆSee details»

Cocrystal Pharma Reports Second Quarter 2023 Financial Results โ€ฆ

Jun 30, 2023 Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, โ€ฆSee details»

linkstock.net © 2022. All rights reserved